Melanoma differentiation associated gene-5 (mda-5) was identified by subtraction hybridization as a novel upregulated gene in HO-1 human melanoma cells induced to terminally differentiate by treatment with IFN-b þ MEZ. Considering its unique structure, consisting of a caspase recruitment domain (CARD) and an RNA helicase domain, it was hypothesized that mda-5 contributes to apoptosis occurring during terminal differentiation. We have currently examined the expression pattern of mda-5 in normal tissues, during induction of terminal differentiation and after treatment with type I IFNs. In addition, we have defined its genomic structure and chromosomal location. IFN-b, a type I IFN, induces mda-5 expression in a biphasic and dose-dependent manner. Based on its temporal kinetics of induction and lack of requirement for prior protein synthesis mda-5 is an early type I IFNresponsive gene. The level of mda-5 mRNA is in low abundance in normal tissues, whereas expression is induced in a spectrum of normal and cancer cells by IFN-b. Expression of mda-5 by means of a replication incompetent adenovirus, Ad.mda-5, induces apoptosis in HO-1 cells as confirmed by morphologic, biochemical and molecular assays. Additionally, the combination of Ad.mda-5 þ MEZ further augments apoptosis as observed in Ad.null or uninfected HO-1 cells induced to terminally differentiate by treatment with IFN-b þ MEZ. The mda-5 gene is located on human chromosome 2q24 and consists of 16 exons, without pseudogenes, and is conserved in the mouse genome. Present data documents that mda-5 is a novel type I IFN-inducible gene, which may contribute to apoptosis induction during terminal differentiation and during IFN treatment. The conserved genomic and protein structure of mda-5 in human and mouse will permit Introduction Differentiation therapy of cancer is based on the hypothesis that transformed tumor cells are derived from normal cells displaying defects in their ability to terminally differentiate thereby resulting in a loss of normal growth control mechanisms (Jiang et al., 1994; Fusenig et al., 1995; Scott, 1997; Garattini and Terao, 2001; Lotem and Sachs, 2002) . A logical extension of this concept is that cancer cells can be induced to differentiate by suitable treatment to reactivate endogenous growth control mechanisms, which in a mutated and genetically damaged cancer cell context can culminate in apoptosis Leszczyniecka et al., 2001) . This possibility has been addressed experimentally utilizing various model systems with the capacity to undergo in vitro differentiation (Lovat et al., 1997; Petersen et al., 1998; Wang and Chen, 2000; Leszczyniecka et al., 2001) . Analysis of gene expression changes in differentiation therapy models provides a powerful experimental tool for delineating and understanding biochemical and molecular events mediating growth arrest of transformed cells Huang et al., 1999a, b; Jiang et al., 2000; Zhang et al., 2000) . In addition, studies in such systems can lead to identification of specific molecules, which are important activators of the terminal differentiation process. Such molecules, in addition to being important analytical tools, also have therapeutic potential in anticancer gene therapy or drug design (Petersen et al., 1998; Zhang et al., 2000; Su et al., 2001; Fisher et al., 2003) .
Combined treatment of HO-1 human melanoma cells with IFN-b and mezerein (MEZ), an antileukemic PKC activating compound, induces terminal differentiation, a process involving irreversible changes in growth kinetics and morphology and ultimately apoptosis Jiang et al., , 1994 . It should be noted that treatment of HO-1 cells with IFN-b alone inhibits cell proliferation and increases melanogenesis, while combined treatment with MEZ induces changes in cell growth characteristics and morphology resembling a terminally differentiated state Jiang et al., , 1994 . To define the molecular aspects of the terminal differentiation process, changes in gene expression patterns were analysed between undifferentiated and IFN-b þ MEZ differentiated cells by subtracted cDNA library screening approaches Jiang et al., 1994) , including rapid subtraction hybridization (RaSH) (Jiang et al., 2000) and differentiation induction subtraction hybridization (DISH) (Huang et al., 1999b) . Melanoma differentiation associated gene-5 (mda-5) was identified as an upregulated sequence in a cDNA subtraction library screening of terminally differentiating HO-1 cells by combined treatment with IFN-b and MEZ, although treatment with IFN-b is also sufficient to induce significant gene expression over basal levels Kang et al., 2002) .
Protein motif analysis through the PROSITE database indicated that mda-5 has unique structural attributes . MDA-5 consists of an amino-terminal caspase recruitment domain (CARD) and a carboxyl-terminal putative RNA helicase domain, representing a novel combination of functional domains that is unprecedented in any previously identified helicase family protein Kovacsovics et al., 2002) . The closest type of 'dual-function heterologous domain fusion' currently recognized in helicase molecules is the fusion of functionally interconnected helicase and RNase motifs found in several putative RNA helicases (Jiang et al., 2000; Bernstein et al., 2001) . The CARD motif is found in diverse apoptotic molecules, such as Apaf-1, caspase-2, -4 and -9 and inhibitors of apoptosis, and is involved in apoptotic signaling by homotypic protein-protein interactions (Hofmann et al., 1997; Bouchier-Hayes and Martin, 2002) .
The carboxyl-terminus two-thirds of MDA-5 contains putative RNA helicase domains . RNA helicases function primarily in destabilizing and unwinding dsRNA using energy generated by ATP hydrolysis (Gorbalenya and Koonin, 1993; Luking et al., 1998) . They belong to helicase superfamily II and are grouped into three subfamilies based on the structure of their ATPase B motifs. The three currently recognized families include the DEAD, DEAH and DExH box containing helicases (Gorbalenya and Koonin, 1993; Luking et al., 1998; Jankowsky and Jankowsky, 2000) . RNA helicases are involved in every step of RNA metabolism including transcription, translation, RNA editing, splicing and degradation (Luking et al., 1998; Jankowsky and Jankowsky, 2000) . RNA helicases consist primarily of motifs for ATPase, binding and unwinding RNA (Gorbalenya and Koonin, 1993; Luking et al., 1998; Jankowsky and Jankowsky, 2000) . MDA-5 contains eight of the nine conserved signatures identifying the DExH subfamily of RNA helicases (Luking et al., 1998; Jankowsky and Jankowsky, 2000) . Among the RNA helicases, a subset where the helicase domain is mostly fused with an RNase III motif has been shown to share further homology with the helicase motif of MDA-5 , the implications of which are presently unclear. Both purified full-length GST-MDA-5 and the recombinant helicase domain of murine MDA-5/Helicard manifest significant dsRNA-dependent ATPase activity Kovacsovics et al., 2002) . DNA-dependent ATPase activity of MDA-5 is much weaker than dsRNA-dependent ATPase activity, supporting its RNA specificity .
Based on its novel structure and distinctive properties, the IFN-b-inducible mda-5 gene is uniquely poised to address relevant questions relating to cellular differentiation, apoptosis and oncogenesis. Analyzing mda-5's molecular properties offers potential to obtain insights into the processes of growth control and apoptosis associated with induction of terminal differentiation and irreversible growth arrest in cancer cells. In this report we begin to address several aspects of mda-5 regulation and perform detailed genomic characterization and expression profile studies. Our results document that mda-5 is an early type I IFN-inducible gene whose expression is elevated in a wide-spectrum of normal and cancer cell types following treatment predominantly with IFN-b and forced expression of mda-5 in HO-1 human melanoma cells induces apoptosis.
Results

Expression pattern of mda-5
The expression pattern of mda-5 was analysed in detail by Northern blot hybridization to determine whether induction of mda-5 was directly responsive to IFN-b or expression was indirectly induced as a result of secondary cellular changes (Figure 1 (only 2-4-fold over basal activity) suggesting a secondary mediator of this response, for example, growth inhibition ( Figure 1a ). The induction of mda-5 was apparent with as little as 0.1 U/ml IFN-b, a dose of IFN which does not alter HO-1 cell growth, suggesting a specific response to this cytokine rather than a secondary effect resulting from growth suppression (Figure 1b) . The induction of mda-5 was gradually increased up to 1000 U/ml of IFN-b in HO-1 cells.
Treatment with the protein synthesis inhibitor cycloheximide (CHX) prior to IFN-b was used to determine whether new protein synthesis was needed for de novo mda-5 gene expression. Pretreatment with CHX increased mda-5 mRNA levels in uninduced and in IFN-b or IFN-b þ MEZ treated HO-1 cells by B1.5-2-fold (Figure 1c ). This enhanced induction of mda-5 in the presence of CHX supports the existence of a message degradation mechanism targeting mda-5 mRNA for destruction. Treatment with actinomycin D (ActD) to inhibit transcription indicated that the mda-5 message has a half-life of B7 h in both IFN-b-and IFNb þ MEZ-treated cells (Figure 1d ). Since the degradation kinetics of mda-5 message was not affected by the presence of MEZ, prolonged maintenance of mda-5 message following combined treatment with IFNb þ MEZ compared to IFN-b alone may reflect cooperative induction by these agents. It is possible that the delayed induction kinetics of mda-5 following MEZ treatment might contribute to the longer and higher induction level seen with the combination. The rapid induction kinetics, sensitivity to IFN-b treatment and the ineffectiveness of CHX in blocking mda-5 induction by IFN-b suggest that mda-5 is an IFN-b early-response gene, not requiring prior protein synthesis for induction.
The induction of mda-5 expression in HO-1 cells by additional type I IFNs was analysed by Northern blot hybridization (Figure 2a ). Both natural and recombinant IFN-b, which induced mda-5 at similar levels, elicited the strongest response among the IFNs tested ( Figure 2a) . The relative extent of induction compared with IFN-b was B75% by IFN-o, B50% by IFN-aB, -aC, -aH, -aI, -aA/D and -a001, and B25% by IFN-aA, -aD, -aF, -aG and -aJ, respectively. Since a similar pattern of induction of HuUBP43 mRNA was also evident in HO-1 cells treated with the same IFN subtypes (Kang et al., 2001 ), it appears that the differential response of mda-5 reflects different potencies of the various IFNs as inducers of the specific IFNinducible genes. Although the extent of message level varied, mda-5 expression induced by IFN-b was observed in most cell types including primary normal human cells (HMEC), immortalized normal human cell lines (FM516-SV, HBL-100 and normal cerebellum) and human cancer cell lines including melanoma, breast cancer, glioblastoma multiforme, cervical cancer, nasopharyngeal cancer, prostate cancer, osteosarcoma and colon cancer (Figure 2b ). While mda-5 expression was increased by B15-fold on average, less than threefold induction was observed in MeWo and T98G cells (Figure 2b ), although the signaling pathways for type I IFNs are reportedly functional in both these cell lines (Friedman et al., 1984; Jackson et al., 2003) . The reduced induction of mda-5 mRNA correlates with relative resistance to IFN-b-induced inhibition of proliferation in MeWo melanoma cells and T98G glioblastoma cells (Tanabe et al., 2000; Jackson et al., 2003) .
The basal level of mda-5 expression in different organs was examined by Northern hybridization of multiple tissue Northern blots (BD Bioscience, Palo Alto, CA, . The steady-state mda-5 message level was extremely low (requiring extended exposure for B3 days for visualization) (Figure 2c ). Among the various tissues, mda-5 message level was highest in spleen and placenta, and almost undetectable in brain, lung, liver, testis and smooth muscle. Higher expression of mda-5 in spleen, but not in thymus, suggests a possible association of mda-5 in humoral immune response and the low basal level of mda-5 message in most tissues highlights the inducible rather than constitutive nature of expression of this gene. Taken together, the Northern blot analysis of mda-5 expression clearly demonstrates that mda-5 is an early and highly sensitive IFN-inducible gene displaying rapid temporal induction kinetics with limited basal expression in normal tissue. In addition, the induction of mda-5 by various subtypes of IFNs in a wide variety of cells implicates mda-5 as a general type I IFN-responsive gene.
Signaling pathways involved in IFN-induced mda-5 expression
The signal transduction pathways involved in IFNstimulated gene (ISG) expression includes activation of JAK family protein tyrosine kinases and STAT proteins (Stark et al., 1998; Samuel, 2001) . Specifically, Jak1, Tyk2, STAT1 and STAT2 play a major role in type I IFN receptor signaling. Based on these considerations, studies of mda-5 induction by IFN were performed using a series of fibrosarcoma cell lines defective in IFN signaling. Derivatives of the 2fTGH fibrosarcoma, wild type in IFN signaling, were compared with U1A, U3A, U4A and U5A cells whose signaling defects could be complemented by expression of tyk2, STAT1, jak1 or IFNAR2, respectively (Pellegrini et al., 1989; Darnell et al., 1994; Lutfalla et al., 1995) . While IFN-b treatment induced mda-5 expression in 2fTGH cells, inducible expression of mda-5 was severely impaired in all of the mutant cell lines (Figure 3) . A partial induction of mda-5 was observed in U1A cells, which was anticipated due to the lack of tight signaling regulation in this clone (Darnell et al., 1994) . This data confirms that the well-established JAK/STAT signaling pathway is directly involved in IFN-inducible mda-5 expression. The fact that mda-5 is an early-response gene whose expression requires JAK/STAT signaling suggests that mda-5 may be a direct target of transcriptional regulation by the ISGF3 complex (Stark et al., 1998; Samuel, 2001 ).
Overexpression of mda-5 induces apoptosis
Ectopic expression of mda-5 reduces colony forming ability by B70% in HO-1 melanoma cells . This effect could be the consequence of mda-5-induced inhibition of cell proliferation or induction of cell death. In order to distinguish between these two (Figure 5a) . The sub-G 0 cell population significantly increased in Ad.mda-5-infected HO-1 melanoma cells (B28%), compared with B3% in Ad.null-infected cells. Moreover, Ad.mda-5 infection combined with MEZ increased the sub-G 0 population, while only combined treatment with IFN-b þ MEZ significantly increased the sub-G 0 population in Ad.null-infected cells. As observed in the MTT assay, only a minor increase in sub-G 0 population was detected by treatment with IFN-b combined with Ad.mda-5 infection (28% for Ad.mda-5 alone and 38% for Ad.mda-5 þ IFN-b). These results confirm that overexpression of mda-5 by itself induces cell death and this effect is augmented by cotreatment with MEZ in a similar manner as observed in terminally differentiating HO-1 cells exposed to the combination of IFN-b þ MEZ.
An apoptotic role of mda-5 was anticipated based on the presence of a CARD-containing motif in the predicted protein . To confirm this possibility, nucleosomal DNA fragmentation and Annexin V-binding assays were performed (Raffray and Cohen, 1997) . Treatment of HO-1 cells with IFNb þ MEZ resulted in the formation of a DNA ladder documenting nucleosomal DNA fragmentation and confirming apoptotic cell death. Although less pronounced, minor DNA degradation was also observed in HO-1 cells treated only with IFN-b (Figure 5b ). In contrast, genomic DNA was not degraded following treatment with MEZ. While infection of Ad.null did not induce nucleosomal DNA fragmentation, infection of Ad.mda-5 induced a DNA ladder indicative of apoptosis (Figure 5b ). Additionally, Annexin V binding, which results from phosphatidylserine exposure during the apoptotic process and precedes apoptotic cell death, was analysed by FACS of double stained adenovirusinfected cells with Annexin V and propidium iodide (Figure 5c ). Annexin V binding was significantly higher in HO-1 cells infected with Ad-mda-5 than in Ad.nullinfected cells (combination of upper and lower right quadrants, 83 and 12.1%, respectively). Furthermore, the Annexin V-positive and propidium iodide-negative cell population (lower-right quadrant), representing apoptotic cell death but not necrotic cell death, also dramatically increased in Ad.mda-5-infected cells when compared with Ad.null-infected cells. In summary, both DNA ladder formation and Annexin V-binding results provide definitive evidence that Ad.mda-5 infection can induce apoptotic cell death in HO-1 cells.
Effects of specific mda-5 domains on cellular growth and survival
Adenoviruses expressing deletions of the putative functional domains of mda-5 were constructed and analysed for their ability to suppress growth compared to the wild-type molecule. Since two major functional domains have been identified mutants were constructed to delete each of these as shown in Figure 6a . These mutants Ad.DCARD deleted for the CARD domain and Ad.DATP deleted for the ATPase function of the RNAhelicase were utilized to infect HO-1 melanoma cells and their effect on growth kinetics was monitored utilizing the MTT assay with full-length wild type expressing Ad.mda-5 and Ad.null as controls. When growth was monitored over 7 days either for direct inhibition or in conjunction with IFN-b, MEZ or combined treatment, it was apparent that deletion of either domain impacted on the ability of the molecule to cause inhibition compared to Ad.mda-5-infected cell populations (data not shown) indicating that they possess functionally relevant activity. Further, it was apparent that both deleted molecules retained some capacity of growth inhibition indicating that they individually possess functionally active domains that possibly combine to contribute to the overall activity of the molecule. Interestingly, deletion of the CARD domain had a greater impact on loss of growth inhibition than deletion of the ATPase domain (Figure 6b ). More defined mutational analyses including finer deletion as well as point mutations will be required to address the role and functionality of each domain in better detail.
Chromosomal localization and genomic structure of mda-5 A GeneBridge4 Radiation Hybrid panel (RH02.05, Research Genetics, Huntsville, AL, USA) was PCR amplified with specific cDNA primers 219 bp apart in the mda-5 cDNA (TGTATTCATTATGCTACA GAACTG/ACTGAGACTGGTACTTTGGATTCT) and the resulting vectors were submitted to http:// www-genome.wi.mit.edu/cgi-bin/contig/rhmapper for genomic mapping. Analysis of the radiation hybrid panel showed that the mda-5 gene localized to chromosome 2q24, between STS markers WI-6270 and D2S354 (5.01 cR and 1.82 cR apart, respectively). This localization was independently confirmed utilizing a BLAST search against the full human genome sequence. The alignment against human chromosome 2 ideogram shown in Figure 7 corresponds to data generated via the BLAST sequence alignment. Screening of a bacterial artificial chromosome (BAC) human genomic library (Research Genetics Inc., Huntsville, AL, USA) with a human cDNA probe (corresponding to sequence AF095844) yielded a clone that spanned the entire mda-5 genomic locus and possibly additional unrelated 5 0 -and 3 0 -flanking sequences. This BAC clone was directly sequenced to determine the exon/intron junctions utilizing appropriate cDNAderived primers followed by alignment of each sequence to the cDNA as described previously (Gopalkrishnan et al., 1998) . Additional subclones were constructed from the BAC clone to facilitate sequencing of difficult regions from BAC DNA and also for cloning specific regions of interest. The results of this analysis are summarized in Figure 7 (middle panel). The locus is comprised of 16 exons and 15 introns (Figure 7, right  panel) . A variant cDNA 202 bp longer in the 3 0 -UTR has been identified that likely utilizes an alternative polyadenylation signal and therefore is an alternative polyadenylation product. It was not possible to identify this variant in multiple tissue Northern blots due to lack of resolution and this variant might correspond to a minor tissue specific isoform. The extension in the 3 0 -UTR occurs in exon 16. An approximately 6 kb upstream, putative transcription regulatory promoter sequence was also present in the BAC clone.
Primer extension analysis utilizing a 5 0 32 P-labeled reverse oriented primer starting at position 228 of AF095844 was performed with conditions described previously (Gopalkrishnan et al., 2000) . A sequence reaction utilizing the same primer enabled precise identification of the transcriptional start site as an 'A' residue, 26 bp upstream of the 5 0 -end of AF095844 (data not shown).
Discussion
IFNs comprise a family of cytokines initially recognized due to their robust induction upon viral infection and their ability to protect treated cells against viral cytopathic effects via modulation of innate and acquired immune responses (Pestka et al., 1987; Stark et al., 1998) . IFNs elicit diverse cell-type-specific responses, including growth inhibition, differentiation and apoptosis, which are frequently exploited in cancer treatment (Fisher and Grant, 1985; Stark et al., 1998; Barber, 2001) . Various IFNs have been used as cancer therapeutics alone and in combination with other chemotherapeutics, including etoposide and tamoxifen, for diverse cancers, including melanoma, breast cancer, osteosarcoma and glioblastoma (Packer et al., 1991; Jia et al., 1999; Lindner et al., 2000; Leszczyniecka et al., 2001) . However, the efficacy of IFNs as cancer therapeutics has been shown to vary widely depending on cancer type and genetic background (Sangfelt and Strander, 2001) .
Two types of IFNs, type I and II, are defined by their interaction with cognate receptors, type I or II receptors, respectively (Pestka, 1997; Stark et al., 1998 (Pestka, 2000) . Although each receptor requires specific signal transduction components, both receptors interact with JAK family protein tyrosine kinases that phosphorylate (Stark et al., 1998; Samuel, 2001) . Phosphorylated STAT proteins translocate into the nucleus and activate transcription of early IFN-responsive genes, which in turn, can modulate the expression of additional genes (Der et al., 1998; Stark et al., 1998) . ISGs regulate diverse biological activities, including apoptosis, immune modulation, protein degradation, transcription, translation, etc. (de Veer et al., 2001) .
Initial characterization of mda-5 demonstrated that it was a transcriptionally regulated ISG whose expression was augmented by MEZ-mediated protein kinase C activation Kang et al., 2002) . Expression of mda-5 was also increased by treatment with TNF-a and double stranded RNA (dsRNA) poly [I] : poly[C], although IFN-b was the most potent inducer . The induction of mda-5 in terminally differentiating HO-1 cells and the signaling pathway of mda-5 induction by IFN is further detailed in this report by Northern blot hybridization. Induction of mda-5 by IFN was found to be an early response not requiring prior protein synthesis and to occur in a spectrum of normal and tumor cells. The induction of mda-5 by IFN requires classical IFN-signal transduction, including the JAK family tyrosine kinases and STAT activation, since mutant cell lines affected for various components in this signaling pathway do not support mda-5 gene expression (Pellegrini et al., 1989; Darnell et al., 1994; Lutfalla et al., 1995) . The primary cellular inducer of mda-5 gene expression is likely IFN-b based on induction kinetics, sensitivity, dependence on IFN-receptor signaling and initial induction by IFN-b.
Analysis of the temporal kinetics of mda-5 expression indicate potentially novel and interesting features when compared to other IFN-dependent differentiation-induced genes isolated in our subtraction hybridization screens Huang et al., 1999b; Kang et al., 2001; Leszczyniecka et al., 2002) . Biphasic induction of mda-5 by IFN-b and poly [I] : poly[C] was evident at the mRNA level. In virus-infected and IFN-treated cells a positive feedback loop of IFN regulation occurs via IRF-3 and IRF-7 activity on IFN promoters (Levy et al., 2002) . In this context, although the first induction phase might be a direct response to IFN, the second surge could result from additional IFN release through a positive feedback loop. However, we observed that expression of additional IFN-b-inducible genes (hUBP43 and hPNPase oldÀ35 ) in the HO-1 system did not exhibit biphasic induction profiles (Kang et al., 2001; Leszczyniecka et al., 2002) . Based on these considerations, the possibility of an alternative mechanism for the second surge in gene expression cannot be excluded. Treatment of HO-1 cells with MEZ in the absence of IFN-b induces mda-5 expression with delayed kinetics and the combination of MEZ þ IFN-b further enhances mda-5 expression (Figure 1a, b) . Since MEZ induces TNF-a expression, which itself is a weak inducer of mda-5, induction of mda-5 by MEZ after prolonged treatment may be a consequence of TNF-a production as well as MEZ-mediated protein kinase C activation (Jiang et al., 2000; Kang et al., 2002) . Delayed kinetics of mda-5 expression by MEZ and serum starvation could also be an indirect effect resulting from inhibition of cell proliferation .
Treatment of HO-1 cells with IFN-b alone inhibits cells proliferation and increases melanogenesis, while combined treatment with MEZ induces irreversible growth arrest and apoptosis Kang et al., 2002) . Adenoviral gene transfer has also been used to analyse the effect of mda-5 on HO-1 melanoma cell growth and survival. Viable cell counts by MTT assay, microscopic observations, DNA nucleosomal ladder formation, FACS analysis for sub-G 0 cell populations and Annexin V binding all confirmed induction of apoptotic cell death by mda-5 (Figures 4  and 5) . MEZ treatment significantly potentiated the induction of apoptosis in Ad.mda-5 expressing cells in a manner similar to that observed when HO-1 cells were treated with the combination of IFN-b þ MEZ (Figure 4b ). These observations suggest that the apoptotic activity of IFN-b in the terminal differentiation process in HO-1 cells might be strongly dependent on mda-5 expression. Studies are currently in progress to test this possibility.
Based on our previous studies indicating that mda-5 contains a CARD domain and transfection of an mda-5 plasmid expression vector into HO-1 cells decreases colony formation , it was anticipated that mda-5 would have proapoptotic activity. Further support for this possibility comes from the demonstration that expression of the murine homologue of mda-5 (mda-5/helicard) in 293 T cells accelerated DNA fragmentation stimulated by treatment with the proapoptotic FasL ligand (Kovacsovics et al., 2002) . We presently provide definitive evidence that mda-5 can induce apoptosis in HO-1 human melanoma cells (Figures 4 and 5) . In the case of the MDA-5 protein, although both CARD and RNA helicase motifs appear to be genuine functional domains, as initially suggested from bioinformatic analysis, the contribution of each motif to MDA-5 activity remains to be defined though both individually retain some amount of growth suppressive properties displayed by the whole molecule ( Figure 6 and data not shown). Studies on murine mda-5/helicard demonstrated specific cleavage of this protein upon treatment of cells with apoptotic ligands, including FasL, TRAIL and staurosporine (Kovacsovics et al., 2002) . Moreover, a truncated recombinantly expressed mouse mda-5/helicard helicase domain, which was shown to localize in the nucleus in transient transfection assays, promoted DNA fragmentation activity in apoptotic cell extracts (Kovacsovics et al., 2002) . These findings support the possibility that each domain of MDA-5 may function independently. However, the in vitro DNA fragmentation promoting activity of mda-5/ helicard was unexpected since the corresponding ATPase activity preferred dsRNA to DNA as a cofactor Kovacsovics et al., 2002) . In addition, nuclear translocation of the helicase domain was observed with the helicase domain alone plus mda-5: novel apoptosis-inducing gene D Kang et al apoptotic ligand treatment, but did not occur following transfection of a full-length mda-5/helicard molecule and similar treatment (Kovacsovics et al., 2002) . Thus, whether this reflects a difference between the human MDA-5 versus the murine MDA-5/HELICARD molecule or each motif of human MDA-5 functions independently or cooperatively in induction of apoptosis requires further experimentation. In addition to mda-5, IFNs induce expression of several additional proapoptotic molecules, including PKR, 2 0 -5 0 OAS, BAK, FAS, TRAIL, TRADD, caspase-4 and -8, thereby activating apoptosis by themselves or in combination with other reagents (de Veer et al., 2001) . Activation of PKR and the 2 0 -5 0 OASRNase L system by dsRNA plays a critical role in IFNinduced apoptosis, although the apoptotic signaling pathway varies with cell type and treatment (Der et al., 1997; Jagus et al., 1999; Saunders and Barber, 2003) . The potential for cooperative interactions between mda-5 and additional IFN-inducible proapoptotic molecules is clearly possible. The requirement for dsRNA to enhance mda-5 ATPase activity might be a common theme in cell commitment to apoptosis by IFN, as already established in the PKR and the 2 0 -5 0 OAS/RNase L systems (Zhou et al., 1997; Saunders and Barber, 2003) . The CARD domain in MDA-5 is anticipated to interact with other apoptotic molecules through CARDmediated protein-protein interactions (Hofmann et al., 1997; Bouchier-Hayes and Martin, 2002) . Thus, detailed analysis of the signaling pathways triggered via mda-5-induced apoptosis is warranted and will provide significant insights into the mechanism by which IFN mediates apoptosis following viral infection and by direct treatment of sensitive cancer cell types.
Chromosomal localization and genomic structure of human mda-5 were analysed by experimental and bioinformatic approaches. mda-5 localized to 2q24 and consists of 16 exons interspersed by 15 introns of variable lengths ( Figure 5 ). The first two exons encode the CARD domain while the RNA helicase motifs are encoded by exons 4-14. The ATPase A motif (TGSGKT) locates to exon 5, ATPase B motif (DECH) and RNA destabilizing motif (GLTAS) to exon 7 and positive charge cluster for potential RNA binding (QARGRARA) to exons 12 and 13, respectively. The homologous position of the site-specific cleavage site observed in mouse mda-5/helicard localizes to exon 3. The overall exon distribution of human mda-5 is also highly conserved in the mouse genome corresponding to the mouse homologue mda-5/helicard located at chromosome 2C1.2-3. Both genomes encode a 16-exon and 15-intron gene structure and the exon/intron boundaries are largely conserved. A notable observation made during human genome database searches with the genomic and cDNA sequence was a region on human chromosome 5 that showed 490% homology to the 150 bp exon 12 of mda-5. This matches to a part of the coding region corresponding to the positive charge cluster in mda-5. The corresponding gene on chromosome 5 is a putative DEAD-box RNA helicase, DDX46 at 5q31. DDX46, also called SF3b, is a stable subunit of the 17S U2 snRNP, involved in pre-mRNA splicing . Other than the part corresponding to exon 12, DDX46 does not have significant sequence homology with any other region of mda-5.
Cytogenetic analysis by comparative genomic hybridization documents alterations in the chromosome 2q24 region in several cancers, although its correlation to cancer etiology is controversial. Frequent gains in chromosome 2q24 were found in hepatoma (Kumon et al., 2001) , esophageal carcinoma (Du Plessis et al., 1999) , inherited ovarian carcinoma (Tapper et al., 1998) and nasopharyngeal carcinoma (Chien et al., 2001) , while losses in 2q24 were reported in basal cell adenocarcinoma of the salivary gland (Toida et al., 2001) , colon tumors (Yeatman et al., 1996) and colorectal tumors (Peng et al., 2002) . Weak linkage of the 2q24 region in multiple sclerosis of Nordic populations was also observed by microsatellite marker typing (Akesson et al., 2002) . Since mda-5 was induced by treatment with IFN-b that has been used for treating patients with multiple sclerosis, mda-5 might associate with the 2q24 region linkage observed in this disease.
The presence of distinct and unrelated functional domains, CARD and helicase in mda-5, a hitherto unique arrangement for any helicase, raises the issue of its evolutionary origin. This is not easily answerable from presently available data including the currently reported information in this manuscript. A possible mechanism is alluded to, by our finding described above that a small region of human mda-5 (exon 12) has strong homology to a distinct gene locus on human chromosome 5 and therefore might be derived from a common source. It is possible that two distinct genes present in organisms lower down in the evolutionary ladder each containing one of these domains, fused to generate mda-5. This possibility is loosely supported by the following observation. Human genome-wide blast searches indicate that mda-5 does not have any additional region comprising parts of the exonic sequences, such as processed pseudogenes. Genome wide analysis of another major IFN-inducible gene, PKR also indicates a lack of pseudogenes, which might imply, based on one school of thought, a relatively short evolutionary history of such genes. In addition, analyses of currently available genomic and EST databases indicate that mda-5 homologues might be restricted to vertebrate species or even more restricted to mammalian organisms, but conclusive evidence will only be available when more sequence information accrues in other systems (Wang and Floyd-Smith, 1998; Leszczyniecka et al., 2003) .
Identification of mda-5 as an IFN-b-mediated differentiation-induced gene in HO-1 cells, having unique attributes, provides a valuable tool in understanding the connections between cellular differentiation, oncogenesis and the dysregulation of normal controls in these processes, particularly in the context of differentiation therapy. Analyzing mda-5's molecular properties offers potential for providing valuable clues relating to gene expression changes and growth control mechanisms induced via the unique combination of helicasemda-5: novel apoptosis-inducing gene D Kang et al mediated RNA unwinding activity and CARD-related apoptotic activity. This report addresses many aspects of mda-5 gene regulation in response to known as well as predicted inducers of expression. In addition, it describes for the first time a detailed genomic characterization and expression profile of a CARD containing helicase molecule. Studies on genomic organization of mda-5 and particularly its promoter will be useful in improving our understanding of existing or identifying new mechanisms of IFN-mediated gene expression. We also document that this new apoptosis promoting molecule is inducible via IFNs in a variety of cell contexts, both of normal and cancer origins, and is therefore not restricted to specific melanoma systems. This spectrum of induction combined with its apoptosisinducing capacity suggests that mda-5 may play a prominent role in IFN-mediated antiviral mechanisms by promoting cell death in the presence of dsRNA. For that reason, mda-5's functional role is likely to be broadly applicable to cellular growth control mechanisms as well as oncogenic and differentiation programs in most cell and tissue contexts. 
Materials and methods
Reagents
Cell lines and culture conditions
The HO-1 human melanoma cell line was derived from a metastatic inguinal node lesion from a 49-year-old woman and maintained in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (FBS) and penicillin/streptomycin (100 U/100 mg/ml) in a 5% CO 2 -95% air-humidified incubator . Additional human cell types included, melanoma (MeWo, LO-1, C8161, SK-MEL wt p53, SK-MEL mut p53, WM35, WM278, SH-1, FO-1), SV40-T-antigen immortalized melanocyte (FM516-SV), normal mammary epithelial (HMEC and HBL-100), breast carcinoma (MCF-7, T47D), colorectal carcinoma (SW613), cervical carcinoma (HeLa), glioblastoma multiforme (T98G, G18), prostate carcinoma (DU-145), nasopharyngeal carcinoma (HONE-1), normal cerebellum (NC) and osteosarcoma (Saos-2) (Jiang et al., 1995 (Jiang et al., , 1996 Su et al., 1998) . All cancer cells and normal cells, except HMEC, were grown in DMEM-10. HMEC was grown in medium provided by Clonetics (Su et al., 1998) . 2fTGH, U1A, U3A, U4A and U5A cells were provided by Dr George Stark (Cleveland Clinic) and grown in DMEM supplemented with 10% FCS and 250 mg/ml hygromycin (Pellegrini et al., 1989; McKendry et al., 1991; Lutfalla et al., 1995) .
RNA isolation and Northern blot analysis
Total RNA was isolated by the guanidinium isothiocyanate lysis followed by the acid phenol extraction procedure and analysed by Northern blot hybridization as described previously ). An EcoRI fragment (2.5 kb) of mda-5 cDNA and 0.7 kb PCR fragment of gapdh were used as a probe. Autoradiograms of Northern blots were quantitated by densitometric analysis using a Molecular Dynamics densitometer (Sunnyvale, CA, USA).
Western blot analysis
Protein extracts were prepared by lysis in 50 mM Tris-HCl (pH 7.5), 0.15 M NaCl, 0.1% SDS, 0.1% Triton X-100, 0.1% Nonidet P-40, 0.5% Na-deoxycholate, 1 mM DTT and protease inhibitors (Roche) and centrifuged at 13 000 r.p.m. for 15 min at 41C. Protein samples (20 mg) were resolved in 10% SDS-PAGE and transferred to a nitrocellulose membrane. Immunodetection of the Western blot was performed as described (Lebedeva et al., 2002) .
Adenovirus construction and infection protocol
The replication incompetent adenoviruses with or without mda-5 (Ad.null, Ad.mda-5, Ad.DATP and Ad.DCARD, respectively) were constructed and amplified as described previously (Holmes et al., 2003) . The DATP mutant of mda-5 (aa 310-484 deletion) was constructed by ligating the 5 0 -StuI fragment to the 3 0 -AlwN1 fragment using T4 DNA polymerase. The DCARD mutant of mda-5 (aa 129-196 deletion) was produced by ligating the 3 0 -HpaI fragment to the 5 0 -HindIII fragment and filled using the Klenow reaction. Amplified virus was purified with BD Adeno-X virus purification kit (BD Clontech) and viral titer was determined by plaque assay in HEK 293 cells. Adenovirus was inoculated onto cells plated the previous day at the indicated multiplicity of infection (m.o.i.) with a minimal volume of media providing cell coverage (4 ml for 10-cm dish, 1 ml for 6-cm dish and 50 ml for each well of 96-well plate). After 2 h of incubation with rotation, the infected cells were refed with fresh media. Infected cells were treated and analysed as indicated in the figure legends.
MTT cell growth and viability assay 100 ml of complete media containing 0.5 mg/ml MTT were refed to cells plated on 96-well plates and previously untreated or adenovirus-infected as described (Lebedeva et al. 2002) . After 3 h, an equal volume of 10% SDS-0.01 N HCl solution was added to the plate and the plate was incubated at 371C overnight to facilitate lysis of the MTT metabolite. Metabolic conversion of MTT by living cell was measured by A595 with a Model 555 Microplate Reader (BioRad, Hercules, CA, USA).
Preparation and analysis of apoptotic genomic DNA Genomic DNA was extracted as described (Lebedeva et al., 2002) . Briefly, HO-1 melanoma cells plated on 10-cm dish (2 Â 10 6 /plate) the previous day were treated or infected with virus as indicated in the figure legend. Cells were harvested by collecting media and trypsinizing attached cells, and lysed in 10 mM Tris-HCl (pH 7.9), 5 mM EDTA, 0.1 M NaCl, 0.5% mda-5: novel apoptosis-inducing gene D Kang et al SDS and 1 mg/ml proteinase K for 2 h in a 371C water bath. The lysate was incubated at 41C overnight after salt adjustment to 1 M with 5 M NaCl. The lysate was centrifuged at 18 000 g for 30 min at 41C and the Hirt supernatant was collected for phenol-chloroform extraction and ethanol precipitation. After treatment with DNA-free RNase A (20 mg/ml) for 10 min at 371C, 5 mg DNA was resolved in a 2% agarose gel.
Fluorescence activated cell-sorting (FACS) analysis
Sub-G 0 cell population and Annexin V binding by apoptotic cells were measured by FACS. For Annexin V binding, cells harvested as in the previous section were washed with PBS once and incubated with FITC-conjugated Annexin V (BD Bioscience, Palo Alto, CA, USA) in 100 ml of 10 mM HEPESNaOH (pH 7.4), 140 mM NaCl and 5 mM CaCl 2 for 15 min at room temperature. Within 30 min after addition of 400 ml of propidium iodide in the incubation buffer to a final volume of 0.5 mg/ml, the cells were analysed with FACS Calibur and CellQuest software (Becton Dickinson, San Jose, CA, USA). For Sub-G 0 cell population, harvested cells were fixed in 70% ethanol at 41C for 30 min. After washing in PBS once, the cells were incubated in PBS containing 0.1 mg/ml propidium iodide, 0.6% Nonidet P-40 and 1 mg/ml RNase A for 30 min at room temperature. Stained cells were analysed as above.
Determination of genomic structure
Sequence data was generated over exon-intron boundaries using an approximately 200 kb BAC clone (Research Genetics, Huntsville, AL, USA) with primers derived from the cDNA sequence AF095844. The BAC DNA was subcloned and mapped by Southern blot analysis using various regions of the cDNA to facilitate sequencing. All exons and introns were sequenced in their entirety, as were all exon-intron boundaries and this was matched to the published human genome sequence database via BLAST searches (Gopalkrishnan et al., 1998 (Gopalkrishnan et al., , 2000 .
